Business Description
Upstream Bio Inc. is a clinical-stage company focused on developing new medicines for serious inflammatory conditions, particularly those affecting the airways and lungs. Its lead treatment, verekitug, is currently being tested in clinical trials for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Founded in 2021 and based in Waltham, Massachusetts, the company is working to bring meaningful relief to patients with these difficult-to-treat conditions.
